Loading...
6 results
Search Results
Now showing 1 - 6 of 6
- Therapeutic potential of vanadium complexes with 1,10-phenanthroline ligands, quo vadis? Fate of complexes in cell media and cancer cellsPublication . Nunes, Patrique; Correia, Isabel; Cavaco, Isabel; Marques, Fernanda; Pinheiro, Teresa; Avecilla, Fernando; Pessoa, Joao Costa(VO)-O-IV-complexes formulated as [(VO)-O-IV(OSO3)(phen)(2)] (1) (phen = 1,10-phenanthroline), [(VO)-O-IV(OSO3) (Me(2)phen)(2)] (2) (Me(2)phen = 4,7-dimethyl-1,10-phenanthroline) and [(VO)-O-IV(OSO3)(amphen)(2)] (3) (amphen = 5-amino-1,10-phenanthroline) were prepared and stability in cell incubation media evaluated. Their cytotoxicity was determined against the A2780 (ovarian), MCF7 (breast) and PC3 (prostate) human cancer cells at different incubation times. While at 3 and 24 h the cytotoxicity differs for complexes and corresponding free ligands, at 72 h incubation all compounds are equally active presenting low IC50 values. Upon incubation of A2780 cells with 1-3, cellular distribution of vanadium in cytosol, membranes, nucleus and cytoskeleton, indicate that the uptake of V is low, particularly for 1, and that the uptake pattern depends on the ligand. Nuclear microscopic techniques are used for imaging and elemental quantification in whole PC3 cells incubated with 1. Once complexes are added to cell culture media, they decompose, and with time most V-IV oxidizes to V-V-species. Modeling of speciation when [(VO)-O-IV(OSO3)(phen)(2)] (1) is added to cell media is presented. At lower concentrations of 1, (VO)-O-IV- and phen-containing species are mainly bound to bovine serum albumin, while at higher concentrations [(VO)-O-IV (phen)n](2+)-complexes become relevant, being predicted that the species taken up and mechanisms of action operating depend on the total concentration of complex. This study emphasizes that for these (VO)-O-IV-systems, and probably for many others involving oxidovanadium or other labile metal complexes, it is not possible to identify active species or propose mechanisms of cytotoxic action without evaluating speciation occurring in cell media.
- Antimicrobial and antitumor activity of S-methyl dithiocarbazate Schiff base zinc(II) complexesPublication . Ramilo-Gomes, Filipa; Alemu, Yemataw; Tekamo, Israel; Cavaco, Isabel; Campos, Débora L.; Pavan, Fernando R.; Gomes, Clara S.B.; Brito, Vanessa; Santos, Adriana O.; Domingues, Fernanda; Luís, Ângelo; Marques, M. Matilde; Pessoa, João Costa; Ferreira, Susana; Silvestre, Samuel; Correia, IsabelSchiff bases (SB) obtained from S-methyl dithiocarbazate and aromatic aldehydes: salicylaldehyde (H2L1), o-vanillin (H2L2), pyridoxal (H2L3) and 2,6-diformyl-4-methylphenol (H3L4), and their corresponding Zn(II)-complexes (1-4), are synthesized. All compounds are characterized by elemental analyses, infrared, UV-Vis, nuclear magnetic resonance spectroscopy and mass spectrometry. The structures of H2L2 and [Zn2(L1)2(H2O)(DMF)] (1a) (DMF = dimethylformamide) are solved by single crystal X-ray diffraction. The SB coordinates the metal center through the Ophenolate, Nimine and Sthiolate atoms. The radical scavenging activity is tested using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, with all ligand precursors showing IC50 values ~40 μM. Cytotoxicity studies with several tumor cell lines (PC-3, MCF-7 and Caco-2) as well as a non-tumoral cell line (NHDF) are reported. Interestingly, 1 has relevant and selective antiproliferative effect against Caco-2 cells (IC50 = 9.1 μM). Their antimicrobial activity is evaluated in five bacterial strains (Klebsiella pneumoniae, Acinetobacter baumannii, Listeria monocytogenes, Pseudomonas aeruginosa and Staphylococcus aureus) and two yeast strains (Candida albicans and Candida tropicalis) with some compounds showing bacteriostatic and fungicidal activity. The minimal inhibitory concentration (MIC90) of HnL against Mycobacterium tuberculosis is also reported, with H2L2 and H3L4 showing very high activity (MIC90 < 0.6 μg/mL). The ability of the compounds to bind bovine serum albumin (BSA) and DNA is evaluated for H3L4 and [Zn2(L4)(CH3COO)] (4), both showing high binding constants to BSA (ca. 106 M-1) and ability to bind DNA. Overall, the reported compounds show relevant antitumor and antimicrobial properties, our data indicating they may be promising compounds in several fields of medicinal chemistry.
- Cytotoxicity of Cryptosula zavjalovensis Kubanin extract against Breast Cancer Cell Line MCF7Publication . Gonzaga, Loveille Jun; Cavaco, Isabel; Fortunato, HelenaThe marine environment is an abundant source of diverse biologically active compounds that demonstrate great potential applications in pharmaceutics and medicine. Although novel biologically active secondary metabolites can be potentially found in bryozoans, there have been a few studies on these organisms. Bryozoans are sessile colonial animals commonly found in great diversity in shallow waters. In this study, samples of the bryozoan Cryptosula zavjalovensis Kubanin were collected from Akkeshi, Japan, and were extracted using ethanol. The crude extract was separated using ethyl acetate (EtOAc) and water to obtain organic and aqueous fractions, respectively. In the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, the EtOAc fraction demonstrated cytotoxicity towards MCF7 breast cancer cells. The EtOAc extract was subsequently fractionated through solid-phase extraction using a gradient of methanol and water (E1 80:20 v/v and E2 100:0 v/v) and using methanol and chloroform (E3 50:50 v/v). Toxicity profiling revealed that the toxicity toward the human MCF7 breast cancer cells of the E2 and E3 fractions is comparable to that of cisplatin, indicating the excellent cytotoxic activity of the EtOAc fractions of C. zavjalovensis. Further studies are thus warranted to isolate the novel compounds in these fractions and determine their potential chemotherapeutic application.
- Copper Complexes with 1,10-Phenanthroline Derivatives: Underlying Factors Affecting Their CytotoxicityPublication . Nunes, Patrique; Correia, Isabel; Marques, Fernanda; Matos, Antonio Pedro; dos Santos, Margarida M. C.; Azevedo, Cristina G.; Capelo, Jose-Luis; Santos, Hugo M.; Gama, Sofia; Pinheiro, Teresa; Cavaco, Isabel; Pessoa, Joao CostaThe interpretation of in vitro cytotoxicity data of Cu(II)-1,10-phenanthroline (phen) complexes normally does not take into account the speciation that complexes undergo in cell incubation media and its implications in cellular uptake and mechanisms of action. We synthesize and test the activity of several distinct Cu(II)-phen compounds; up to 24 h of incubation, the cytotoxic activity differs for the Cu complexes and the corresponding free ligands, but for longer incubation times (e.g., 72 h), all compounds display similar activity. Combining the use of several spectroscopic, spectrometric, and electrochemical techniques, the speciation of Cu-phen compounds in cell incubation media is evaluated, indicating that the originally added complex almost totally decomposed and that Cu(II) and phen are mainly bound to bovine serum albumin. Several methods are used to disclose relationships between structure, activity, speciation in incubation media, cellular uptake, distribution of Cu in cells, and cytotoxicity. Contrary to what is reported in most studies, we conclude that interaction with cell components and cell death involves the separate action of Cu ions and phen molecules, not [Cu(phen)(n)] species. This conclusion should similarly apply to many other Cu-ligand systems reported to date.
- Exploring the therapeutic potential of Cu(II)-complexes with ligands derived from pyridoxalPublication . Nunes, Patrique; Marques, Fernanda; Cavaco, Isabel; Pessoa, Joao Costa; Correia, IsabelThree new copper(II) complexes formulated as [Cu(L)(X)], where X = H2O or Cl and H2L is a Schiff base (H2L1,2) or its reduced version ((H3LCl)-Cl-3) derived from pyridoxal, are prepared, as well as two ternary complexes [Cu(L) (phen)] also containing 1,10-phenanthroline. All compounds are characterized by the usual techniques: elemental analyses, ESI mass spectrometry, UV-Vis absorption, FTIR and EPR spectroscopies. The ligands co-ordinate the Cu(II) center forming complexes with square-planar based geometries. Their antioxidant properties are evaluated with a radical scavenging activity assay, with one of the ligand precursors showing activity higher than the positive control, ascorbic acid. The antiproliferative activity of all compounds is evaluated against two cancer cell lines: ovarian (A2780) and breast (MCF7). All complexes show moderate to excellent activity with the ternary Cu-complexes showing IC50 values between 0.7 and 9.3 mu M after 24 h of incubation, values much lower than those reported for cisplatin, the reference drug. The hydrolytic stability of the complexes and their ability to bind albumin and DNA are evaluated by spectroscopic techniques, showing that the compounds bind bovine serum albumin. The [Cu(L)(phen)] complexes show ability to target DNA via intercalation.
- Strategies and approaches of companies in Portugal and Spain in complying with the REACH regulationPublication . Talampas, Sheila, I; Cavaco, Isabel; Sainz, DanielThe implementation of the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulation had been viewed to be the most ambitious chemicals legislation in the world and had placed a great challenge among the European Union (EU) member states. While government regulatory agencies were focused on how they can successfully implement and enforce the legislation, the industries' concern was to guarantee the compliance with the regulation. Despite the progress, implementation of the regulation still experienced significant problems in the quality of the information provided by companies in their registration dossiers. Given that the success of the REACH process depended primarily on the adequate and reliable information supplied by industries, there was a need to document and manage the knowledge gained and generated since its implementation. Data from survey questionnaires revealed that major issues and concerns identified by industries consisted of communication problems among participants in the implementation of the Substance Information Exchange Forum (SIEF), failure to reach an agreement on the sharing of existing data, testing cost and lack of response from suppliers in the use of substance and correction of errors in the safety data sheet. To address these issues and concerns, the European Chemicals Agency (ECHA) implemented the SIEF for EU-based chemical industries to form consortiums and jointly carry out registration and dossier submission. Participants identified SIEF as the best practice enabling companies to complete their registration and dossier submission, as well as the most efficient method in complying with REACH regulation.